| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.65B | +5.7% |
| Cost of Revenue | $4.31B | +6.1% |
| Gross Profit | $3.34B | +5.2% |
| R&D Expense | $114.3M | -2.0% |
| SG&A Expense | $1.44B | +7.1% |
| Operating Income | $1.14B | -12.0% |
| Pre-tax Income | $935.3M | -17.4% |
| Income Tax | $219.4M | -16.4% |
| Net Income | $581.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.25B | -19.0% |
| Accounts Receivable | $1.52B | +13.7% |
| Inventory | $1.17B | +11.2% |
| Current Assets | $4.25B | +2.0% |
| Total Assets | $18.30B | +1.6% |
| Current Liabilities | $2.07B | +13.6% |
| Long-term Debt | $4.78B | +0.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.36B | -2.9% |
| Investing Cash Flow | -$660.6M | +78.7% |
| Financing Cash Flow | -$1.05B | -161.7% |
| -30.7% |
| EPS (Basic) | $1.46 | -29.8% |
| EPS (Diluted) | $1.45 | -29.6% |
| Total Liabilities |
| $8.14B |
| +4.9% |
| Stockholders' Equity | $10.09B | -0.9% |